Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review

Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults

(2014) Nozomi Takeshita et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005–2012

(2014) Yu Liu et al.   VACCINE

Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in Taiwan

(2014) Li-Min Huang et al.   VACCINE

WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012

(2013) Dennis W. Trent et al.   BIOLOGICALS

Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain

(2013) Chiaki Miyazaki et al.   Clinical and Vaccine Immunology

Is a Booster Dose Necessary in Children after Immunization with Live Attenuated Japanese Encephalitis Vaccine?

(2013) U. Y. Choi et al.   JOURNAL OF TROPICAL PEDIATRICS

Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children

(2013) Emmanuel Feroldi et al.   Human Vaccines & Immunotherapeutics

A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines

(2012) E. O. Erra et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine

(2012) Tabitha Woolpert et al.   VACCINE

Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children

(2012) Kenji Okada et al.   VACCINE

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)

(2012) Akiko Kikukawa et al.   VACCINE

Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial

(2012) Emmanuel Feroldi et al.   Human Vaccines & Immunotherapeutics

Effectiveness of the Viet Nam Produced, Mouse Brain-Derived, Inactivated Japanese Encephalitis Vaccine in Northern Viet Nam

(2012) Florian Marks et al.   PLoS Neglected Tropical Diseases

Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports

(2011) Na Jia et al.   BMC INFECTIOUS DISEASES

Estimated global incidence of Japanese encephalitis:

(2011) Grant Campbell et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

New Japanese encephalitis vaccines: alternatives to production in mouse brain

(2011) Scott B Halstead et al.   Expert Review of Vaccines

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine

(2011) Peter E Nasveld et al.   Human vaccines & immunotherapeutics

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine

(2011) Peter E. Nasveld et al.   Human vaccines & immunotherapeutics

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

(2011) Susanne Eder et al.   VACCINE

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®

(2011) Elisabeth Schuller et al.   VACCINE

Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case–control study

(2011) Charung Muangchana et al.   VACCINE

IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine

(2010) Mohan Babu Appaiahgari et al.   Expert Review of Vaccines

Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds

(2010) Kulkanya Chokephaibulkit et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine

(2010) Thanyawee Puthanakit et al.   VACCINE

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

(2010) Katrin Dubischar-Kastner et al.   VACCINE

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

(2010) Joseph Torresi et al.   VACCINE

Effectiveness of One Dose of SA 14-14-2 Vaccine against Japanese Encephalitis

(2009) Rashmi Kumar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study

(2009) Elisabeth Schuller et al.   VACCINE

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

(2009) A. Kaltenböck et al.   VACCINE

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

(2009) A. Kaltenböck et al.   VACCINE

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses

(2008) Young Mo Sohn et al.   VACCINE

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

(2008) E. Schuller et al.   VACCINE

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

(2008) Salvacion Gatchalian et al.   VACCINE